DGCI
- Health
DCGI orders withdrawal of cancer drug Olaparib for certain treatments
New Delhi: The Drug Controller General of India has asked drug regulators in all states and Union territories to withdraw AstraZeneca’s anti-cancer drug Olaparib tablets for treatment in patients who have received…
- India
Fake medicines: After WHO alerts, DGCI asks states to hold strict vigil
New Delhi: The Drugs Controller General of India (DCGI) has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified…
- India
Abbott recalls antacid Digene gel, DGCI issues alert
Leading American multinational medical devices and health care company, Abbott voluntarily recalled its antacid Digene gel after the Drugs Control General of India (DCGI) received a complaint on 9 August, alleging bitter…
